Overview of success of EVAR: progress to date.
Endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms has been challenged by a number of groups, and the shortcomings of this procedure have been documented in the scientific literature. However, patients and physicians continue to pursue this procedure as a viable means of treating abdominal aortic aneurysms. Both device evolution and advancement of technical skills have led to dramatic improvements in the outcomes of EVAR within the last decade. These improvements and accomplishments have also been chronicled in the literature. This review looks at the successes of EVAR, based on both US Food and Drug Administration trials and independent studies comparing conventional open repair and endovascular repair.
Longo
G Matthew
GM
Division of Vascular Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Eskandari
Mark K
MK
D017544:Aortic Aneurysm, Abdominal / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000592:standards* / Q000639:trends; D019917:Blood Vessel Prosthesis Implantation / Q000592:standards / Q000639:trends*; D002986:Clinical Trials as Topic; D018795:Device Approval; D004869:Equipment Safety; D005500:Follow-Up Studies; D006801:Humans; D015337:Multicenter Studies as Topic; D011474:Prosthesis Design / Q000592:standards / Q000639:trends*; D012189:Retrospective Studies; D015607:Stents / Q000592:standards* / Q000639:trends; D014481:United States; D014486:United States Food and Drug Administration